Literature DB >> 28249265

Role of the G Protein-Coupled Bile Acid Receptor TGR5 in Liver Damage.

Maria Reich1, Caroline Klindt, Kathleen Deutschmann, Lina Spomer, Dieter Häussinger, Verena Keitel.   

Abstract

BACKGROUND: TGR5 (G protein-coupled bile acid receptor 1, M-Bar) is a G protein-coupled cell surface receptor responsive to bile acids (BA) and different steroid hormones. TGR5 mRNA is detected almost ubiquitious in human and rodent tissues with a very high expression in gallbladder, liver and intestine. In liver, TGR5 is found in sinusoidal endothelial cells, Kupffer cells and cholangiocytes. Activation of TGR5 triggers an elevation of intracellular cyclic AMP and further downstream signalling. Key Messages: TGR5 exerts anti-inflammatory effects, protects cholangiocytes from BA-induced toxicity, promotes cholangiocyte secretion and proliferation and reduces portal perfusion pressure. Furthermore, TGR5 mediates gallbladder filling. TGR5 knockout mice have a smaller BA pool size with altered composition and develop more severe liver injury after BA feeding, common bile duct ligation or injection of lipopolysaccharide. The absence of TGR5 also reduces the proliferative and regenerative capacity after partial hepatectomy or liver damage. Stimulation of TGR5 signalling can improve steatohepatitis, portal hypertension and hepatic inflammation in rodent models of liver damage. However, TGR5 activation also promotes the proliferation of cystic and malignant-transformed cholangiocytes.
CONCLUSIONS: TGR5 plays an important role in the protection of the liver from BA toxicity under cholestatic conditions. Stimulation of the receptor prevents excessive liver damage in rodent models of cholestasis, steatohepatitis, liver fibrosis and inflammation and also promotes liver regeneration. However, the activation of TGR5-dependent signalling may also trigger proliferation and apoptosis resistance of cystic cholangiocytes and malignantly transformed cholangiocytes, thus promoting cyst growth in polycystic liver disease or progression of cholangiocarcinoma. Depending on the type of liver disease stimulation as well as inhibition of TGR5, signalling may present a useful therapeutic approach.
© 2017 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28249265     DOI: 10.1159/000450917

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  16 in total

Review 1.  The cholangiocyte primary cilium in health and disease.

Authors:  Adrian P Mansini; Estanislao Peixoto; Kristen M Thelen; Cesar Gaspari; Sujeong Jin; Sergio A Gradilone
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-06-15       Impact factor: 5.187

Review 2.  Mechanisms of bile acid mediated inflammation in the liver.

Authors:  Man Li; Shi-Ying Cai; James L Boyer
Journal:  Mol Aspects Med       Date:  2017-07-01

3.  Bile Acid Toxicity and Protein Kinases.

Authors:  Atilla Engin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Reversal of NAFLD After VSG Is Independent of Weight-Loss but RYGB Offers More Efficacy When Maintained on a High-Fat Diet.

Authors:  Ankita Srivastava; Matthew Stevenson; Jenny Lee; Christopher Hall; Thomas Palaia; Chaohui Lisa Zhao; Raymond Lau; Collin Brathwaite; Louis Ragolia
Journal:  Obes Surg       Date:  2022-04-14       Impact factor: 3.479

Review 5.  Hepatic Macrophages in Liver Injury.

Authors:  Zhao Shan; Cynthia Ju
Journal:  Front Immunol       Date:  2020-04-17       Impact factor: 7.561

6.  MAIT cell activation in adolescents is impacted by bile acid concentrations and body weight.

Authors:  A Mendler; A Pierzchalski; U Rolle-Kampczyk; G Herberth; M Bauer; S Röder; A Sattler; M Standl; M Borte; M von Bergen
Journal:  Clin Exp Immunol       Date:  2020-02-17       Impact factor: 4.330

7.  TGR5 activation attenuates neuroinflammation via Pellino3 inhibition of caspase-8/NLRP3 after middle cerebral artery occlusion in rats.

Authors:  Hui Liang; Nathanael Matei; Devin W McBride; Yang Xu; Zhenhua Zhou; Jiping Tang; Benyan Luo; John H Zhang
Journal:  J Neuroinflammation       Date:  2021-02-02       Impact factor: 8.322

Review 8.  Roles of the inflammasome in the gut‑liver axis (Review).

Authors:  Junfeng Wang; Rui Dong; Shan Zheng
Journal:  Mol Med Rep       Date:  2018-11-20       Impact factor: 2.952

9.  Roux-en-Y Gastric Bypass Surgery-Induced Weight Loss and Metabolic Improvements Are Similar in TGR5-Deficient and Wildtype Mice.

Authors:  Zheng Hao; R Leigh Townsend; Michael B Mumphrey; Thomas W Gettys; Sangho Yu; Heike Münzberg; Christopher D Morrison; Hans-Rudolf Berthoud
Journal:  Obes Surg       Date:  2018-10       Impact factor: 4.129

10.  Intestinal flora imbalance affects bile acid metabolism and is associated with gallstone formation.

Authors:  Qiang Wang; Chenjun Hao; Wenchao Yao; Defu Zhu; Haifeng Lu; Long Li; Biao Ma; Bei Sun; Dongbo Xue; Weihui Zhang
Journal:  BMC Gastroenterol       Date:  2020-03-06       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.